Industry News

BeiGene is planning to break ground in 2022 on a pharmaceutical manufacturing and research center in Hopewell, N.J. Located on the Princeton West Innovation Campus, the integrated complex will provide 400,000 sf of dedicated space for commercial-stage production of innovative cancer therapies. Offering up to 16,000 liters of biologics capacity, the facility will also include clinical R&D labs and collaborative office environments. IPS is the architect and engineer for the project, which will be built by DPR Construction.

Rocky Mountain Laboratories began construction in December of 2021 on a $93 million animal research vivarium in Hamilton, Mont. Accelerating the detection and mitigation of emerging infectious diseases, the 120,000-sf structure will provide climate-controlled environments for rodents, ticks, bats, and other species. The technology-rich building will also house an analytical lab and collaborative workspaces for researchers and staff.

Moderna is partnering with Alexandria Real Estate Equities to create a 462,000-rsf headquarters and research facility at the Alexandria Center development at One Kendall Square. Accelerating the discovery and development of mRNA vaccines and therapeutics, the collaborative structure will feature leading-edge R&D labs, sophisticated offices, and engaging gathering spaces.

Tonix Pharmaceuticals broke ground in August of 2021 on the 45,000-sf Advanced Development Center in Dartmouth, Mass. Enabling the production of clinical-stage vaccines for COVID-19 and other infectious diseases, the BSL-2 facility will utilize single-use bioreactors and purification suites for optimal efficiency and flexibility. The cGMP center will also offer state-of-the-art research, development, and analytical suites. Approximately 70 scientists, technicians, and manufacturing staff will work in the turnkey building. 

Ivanhoé Cambridge and Lendlease will break ground in summer of 2022 on a 320,000-sf life sciences facility in Boston. Designed by SGA, the nine-story building will provide state-of-the-art labs, offices, and collaboration spaces for biomedical and pharmaceutical tenants. Offering BSL-1 and BSL-2 research environments, the amenity-rich structure will include a multipurpose ground floor, a parking garage, and numerous outdoor areas.